EMA of Substance Use in Homeless Youth

Not Applicable

Completed

• Conditions: Substance Use

• Registration Number: NCT04884087
• Lead Sponsor: Nationwide Children's Hospital

Brief Summary

The proposed study will provide critical information on Ecological Momentary Assessment (EMA) design characteristics that promote retention in a vulnerable and under-represented population in research-youth experiencing homelessness. The study will use an EMA app to collect substance use, mood, craving, social surroundings, and trauma measures over a 14-day period in youth age 18-24 (n=40) recruited from Star House, a homeless youth drop-in center. Youth will be randomized in 2x2 factorial design (fixed incentive model vs. prize-based model; random assessment 3x vs. 6x per day).

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-24
• Study First Submitted: 2021-05-07
• Study First Submitted QC: 2021-05-07
• Study First Posted: 2021-05-12
• Primary Completion: 2021-06-30
• Study Completion: 2021-06-30
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-15
• Last Update Posted: 2023-03-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• currently homeless, defined as lacking a fixed, regular, and adequate nighttime residence.
• report any of the following past-month frequencies of substance use (NIDA ASSIST screen) used in prior EMA studies: a) heavy episodic or "binge" drinking (≥4 drinks per day for women/≥5 drinks for men) ≥2 days per month ; b) marijuana use ≥2 days per week; or c) any illicit drug use.

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
Length of Time	Baseline to end of trial (day 14)	Total length of time in days using EMA (range: 1-14 days). Higher values represent greater length of time EMA was used.
Percent Completion	Baseline to end of trial (day 14)	Percent of EMA surveys completed (0-100%). Higher values represent a larger percentage of EMA surveys completed.

Trial Locations

Locations (1)

Nationwide Children's Hospital; 🇺🇸 Columbus, Ohio, United States